생체흡수성 혈관 스캐폴드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global bioresorbable vascular scaffold market size is expected to reach USD 453.55 Million in 2034 from USD 222.03 Million in 2025, growing at a CAGR of 8.26 during 2026-2034.This market is growing steadily as advancements in cardiovascular treatments drive demand for innovative medical devices. Bioresorbable vascular scaffolds are used to support blood vessels temporarily and then dissolve naturally, reducing long-term complications associated with traditional stents. The increasing prevalence of cardiovascular diseases is a major factor contributing to market growth. Additionally, the growing adoption of minimally invasive procedures is supporting the use of advanced scaffold technologies.

Key drivers include advancements in medical research and the rising demand for safer treatment options. Bioresorbable scaffolds offer advantages such as reduced risk of late thrombosis and improved vessel healing. The expansion of healthcare infrastructure and increasing investments in research and development are also supporting market growth. Furthermore, regulatory approvals and clinical trials are encouraging the adoption of these innovative devices.

Future prospects for this market remain highly promising, with continued innovation expected to enhance device performance and patient outcomes. The development of next-generation scaffolds with improved materials and designs will drive growth. Emerging markets are anticipated to witness increased adoption due to improving healthcare systems. As the demand for advanced cardiovascular treatments continues to rise, the bioresorbable vascular scaffold market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Everolimus-eluting Device
• Novolimus-eluting Device
• Sirolimus-eluting Device
• Others (Rapamycin, etc.)

By Disease Type

• Coronary Artery Disease
• Peripheral Artery Disease

By Material Type

• Poly-L-Lactic Acid (PLLA)
• Tyrosine-derived Polycarbonate
• Others (Polydioxanone, etc.)

By End User

• Hospital
• Ambulatory Surgical Center
• Cardiac Catheterization Lab
• Others (research institutes, etc.)

COMPANIES PROFILED

• Kyoto Medical Planning Co. Ltd., Biotronik Group of Companies., REVA Medical, Elixir Medical, Arterius, Meril Life Sciences Pvt. Ltd., S3V Vascular Technologies, Zorion Medical, Medtronic (development phase).

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Everolimus-eluting Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Novolimus-eluting Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sirolimus-eluting Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others (Rapamycin, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: BY DISEASE TYPE >2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Type
• 5.2. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Material Type
• 6.2. Poly-L-Lactic Acid (PLLA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Tyrosine-derived Polycarbonate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others (Polydioxanone, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cardiac Catheterization Lab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others (research institutes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Disease Type
  • 8.2.3 By Material Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Disease Type
  • 8.3.3 By Material Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Disease Type
  • 8.4.3 By Material Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Disease Type
  • 8.5.3 By Material Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Disease Type
  • 8.6.3 By Material Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIORESORBABLE VASCULAR SCAFFOLD INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Kyoto Medical Planning Co. Ltd
  • 10.2.2 Biotronik Group Of Companies
  • 10.2.3 REVA Medical
  • 10.2.4 Elixir Medical
  • 10.2.5 Arterius
  • 10.2.6 Meril Life Sciences Pvt. Ltd
  • 10.2.7 S3V Vascular Technologies
  • 10.2.8 Zorion Medical
  • 10.2.9 Medtronic (development Phase)